logo
Nikkei to revise rule to address spinoff listings in Nikkei 225

Nikkei to revise rule to address spinoff listings in Nikkei 225

Nikkei Asia8 hours ago

TOKYO -- Nikkei announced on Monday a proposed revision to the methodology of the Nikkei 225 to address cases in which constituent companies list subsidiaries or business units through spinoffs. The proposed change is designed to preserve index continuity during such corporate actions.
Under the proposal, a spun-off entity would be temporarily included in the index calculation from the ex-rights date until its official listing on the Tokyo Stock Exchange. Because the spun-off company will not have a market price prior to listing, the offering or reference price would be used for index adjustment. The entity would then be removed from the index on the business day following its listing.
Nikkei is inviting public feedback on the proposal through its official Nikkei Index website until the end of June. The results of the consultation are expected to be published in July.
The revision was prompted by Sony Group's plan to spin off its financial services arm Sony Financial Group via a direct listing scheduled for September.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nikkei to revise rule to address spinoff listings in Nikkei 225
Nikkei to revise rule to address spinoff listings in Nikkei 225

Nikkei Asia

time8 hours ago

  • Nikkei Asia

Nikkei to revise rule to address spinoff listings in Nikkei 225

TOKYO -- Nikkei announced on Monday a proposed revision to the methodology of the Nikkei 225 to address cases in which constituent companies list subsidiaries or business units through spinoffs. The proposed change is designed to preserve index continuity during such corporate actions. Under the proposal, a spun-off entity would be temporarily included in the index calculation from the ex-rights date until its official listing on the Tokyo Stock Exchange. Because the spun-off company will not have a market price prior to listing, the offering or reference price would be used for index adjustment. The entity would then be removed from the index on the business day following its listing. Nikkei is inviting public feedback on the proposal through its official Nikkei Index website until the end of June. The results of the consultation are expected to be published in July. The revision was prompted by Sony Group's plan to spin off its financial services arm Sony Financial Group via a direct listing scheduled for September.

Tokyo stocks lifted by tech gains, US-China trade talks eyed
Tokyo stocks lifted by tech gains, US-China trade talks eyed

The Mainichi

time9 hours ago

  • The Mainichi

Tokyo stocks lifted by tech gains, US-China trade talks eyed

TOKYO (Kyodo) -- Tokyo stocks rose Monday as buying of tech shares helped the Nikkei index close above the key 38,000 line, but further gains were limited before U.S.-China trade talks. The 225-issue Nikkei Stock Average ended up 346.96 points, or 0.92 percent, from Friday at 38,088.57. The broader Topix index finished 16.08 points, or 0.58 percent, higher at 2,785.41. On the top-tier Prime Market, gainers were led by pharmaceutical, bank and electric appliance issues. The U.S. dollar weakened to the lower 144 yen range in Tokyo on selling after the currency approached the 145 yen line as stronger-than-expected U.S. May employment data, released Friday, reduced concerns about a slowdown in the labor market. The Nikkei benchmark ended above 38,000 for the first time since late May, as heavyweight semiconductor-related issues tracked gains by their U.S. counterparts. Bank shares were also higher on hopes for greater profits as Japanese bond yields climbed. Meanwhile, investors awaited the outcome of high-level trade talks between the United States and China in London on Monday to see whether the world's two largest economies will make progress in easing tensions, brokers said. "Japan doesn't seem to have made much progress (in tariff talks with the United States), so if investors can see other negotiations moving forward, it may give them some relief," said Toshikazu Horiuchi, equity strategist at IwaiCosmo Securities Co. Pharmaceutical stocks led risers, with Otsuka Holdings jumping over 5 percent after the company said Friday that interim clinical trial data for its chronic kidney disease treatment showed encouraging results.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store